eFFECTOR Therapeutics Provides Pipeline and Business Updates
top of page
Companies in the News
Tomivosertib development strategy updated, including addition of a new cohort in Phase 2b KICKSTART trial in non-small cell lung cancer...
- Jan 20, 2022
Nuvation Bio Announces FDA Clearance of IND Application for NUV-868 for the Advanced Solid Tumors
NEW YORK, Jan. 20, 2022 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet...
- Jan 6, 2022
Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs
Amgen wants its future drugs to be multispecific, and so the biopharmaceutical company selected Generate Biomedicines for a $1.9 billion...
- Dec 4, 2021
Landus and Indigo Join Forces to Elevate Farmers’ Profitable Role in Digital Ag Landscape
Landus farmers will gain access to new carbon revenue stream and digital grain marketing tools AMES, Iowa (December 2, 2021) – Landus,...
- Nov 19, 2021
Generate Biomedicines Announces Raise of $370 Million to Advance its Drug Generation Platform
Cambridge, Mass, November 18, 2021 – Generate Biomedicines, whose machine learning-powered Generative Biology platform can rapidly invent...
- Nov 4, 2021
Tessera Therapeutics Announces R&D Collaboration with Cystic Fibrosis Foundation
Tessera’s Gene WritingTM Technology is Designed to Simultaneously Correct Multiple Genetic Mutations as well as to Write Genes in Their...
- Oct 20, 2021
Laronde banks $440M to ramp up RNA-based meds that could turn cells into protein factories
Laronde launched out of Flagship Labs this year with a lofty vision: to deliver as many as 100 new RNA medicines over the next 10 years....
- Oct 7, 2021
Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases
Redefining neuroscience research and development with a data-driven precision neuroscience platform to develop targeted therapies for...
- Aug 25, 2021
eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company
Common stock and warrants expected to commence trading on Nasdaq on August 26, 2021 under the ticker symbols EFTR and EFTRW SAN DIEGO,...
bottom of page